The FY2025 (Dec) proxy of Personalis names 21 peer companies for pay. Among Personalis and these peers, CEO pay was 3rd highest of 4 and total shareholder return was 2nd highest of 4.
3rd highest of 4in Personalis and its pay peers, FY2025 (Dec) by CEO pay:
$3.3M$13.5M
2nd highest of 4in Personalis and its pay peers, FY2025 (Dec) by total shareholder return:
$0$1,494
Pay peer group, FY2025 (Dec) proxy
| GeneDx Holdings | ||
| Pacific Biosciences Of California | ||
| Outset Medical | ||
| Adaptive Biotechnologies1 | Not disclosed | Not disclosed |
| Akoya Biosciences1 | Not disclosed | Not disclosed |
| Alector1 | Not disclosed | Not disclosed |
| Biodesix | Not disclosed | Not disclosed |
| CareDx1 | Not disclosed | Not disclosed |
| Castle Biosciences1 | Not disclosed | Not disclosed |
| Codexis1 | Not disclosed | Not disclosed |
| CytomX Therapeutics1 | Not disclosed | Not disclosed |
| Fulgent Genetics1 | Not disclosed | Not disclosed |
| Mesa Laboratories1 | Not disclosed | Not disclosed |
| Nautilus Biotechnology | Not disclosed | Not disclosed |
| OraSure Technologies | Not disclosed | Not disclosed |
| Quanterix1 | Not disclosed | Not disclosed |
| Seer1 | Not disclosed | Not disclosed |
| Standard BioTools1 | Not disclosed | Not disclosed |
| Sutro Biopharma1 | Not disclosed | Not disclosed |
| Twist Bioscience1 | Not disclosed | Not disclosed |
| Veracyte1 | Not disclosed | Not disclosed |
21 companies
Changes by year
No proxy on file names a change to the peer group.
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.